Keith Maher

Keith Maher, M.D., is a Managing Director at Armistice Capital, LLC based in New York, NY. In this role, he is responsible for overseeing investment management activities, serving as a representative of the firm in key board positions and managing long-short equity strategies within the healthcare and biotechnology sectors. His responsibilities include portfolio analysis, sourcing investment opportunities, and representing Armistice Capital’s interests as a 'director by deputization' in public company boardrooms.

Dr. Maher's investment focus lies specifically in healthcare and biotech asset classes, demonstrated by his leadership in strategic investments in companies such as Vaxart and Aytu BioPharma. He has played significant roles in corporate governance, often joining target company boards to align strategic decisions with Armistice’s investment objectives. His approach involves active engagement with management teams and leveraging industry expertise to drive shareholder value.

With a medical degree (M.D.), Dr. Maher combines clinical expertise with investment acumen, previously holding senior positions before joining Armistice Capital in 2019. He is recognized for his contributions to successful litigation outcomes and governance reforms, winning notable securities cases in federal courts that clarified the rights of institutional investors in boardroom representation and short-swing trading regulations.